Homepage
WuXi Biology
A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic
Poster: Isogeneic Trop-2 Model for Evaluating Anti-Trop-2 ADCs
Learn about the development of an isogeneic Trop-2 expression heterogeneity model for evaluating the bystander killing activity of anti-Trop-2 ADCs
Protocol Publication: Development of Paclitaxel-Resistant Models
Learn about methods for establishing gastric cancer and breast cancer cell lines and tumor models that are stably resistant to paclitaxel
Poster: Novel ROR1 Antibody for Predictive Biomarker Detection
Learn about the development of a recombinant rabbit monoclonal antibody which demonstrates superior sensitivity and specificity for ROR1
Enabling Unbounded Possibilities
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and into the clinic. Our world-class discovery platform is backed by nearly 3000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules, oligonucleotides, and peptides to antibodies, cell, and gene therapies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.
Speak with a SpecialistTarget Discovery to Candidate Selection and Beyond
Supporting stand-alone and integrated projects
Comprehensive platform from target ID to drug candidates
Target Identification and Validation
Finding druggable targets
Comprehensive coverage of target classes and therapeutic modalities
Hit Identification
Screening services to accelerate drug discovery
Integrated platform with diverse methods to identify hit compounds
Hit Validation and Early Optimization
Confirming chemistry tractability
In vitro screening platform to support medicinal chemistry
Lead Discovery Services
Enhancing the most promising compounds
In vivo services to accelerate drug discovery
Preclinical Drug Development
Enabling the selection of the best candidates
Integrated platform for preclinical R&D to accelerate timelines
Investigational New Drug Discovery
Comprehensive IND enabling testing platform
Supporting clients from research to market
Latest Science
Severe Hyperglycemia and Hyperlipidemia Alter Tumor Growth and Immune Profiles
VIEW PosterAlterations in Energy Metabolism and Lipogenesis in GIPR/GLP-1R Agonist-Treated MASH Mice
VIEW PosterLatest Poster
Precision-Cut Tissue Slices to Advance Drug Discovery
Precision-Cut Tissue Slices
VIEW PosterNovel ROR1 Antibody with High Specificity and Sensitivity
VIEW PosterLatest Poster
Development of NK Humanized Mouse Models
Development of NK Humanized Mouse Models
VIEW PosterLatest Poster
Isogeneic Trop-2 Model for Evaluating Anti-Trop-2 ADCs
Isogeneic Trop-2 Model for Evaluating Anti-Trop-2 ADCs
VIEW PosterLatest Poster
HPV18-Related Cancer Model Development
HPV18-Related Cancer Model Development
VIEW PosterLatest Publication
DNA-Compatible Huisgen Cycloaddition
DNA-Compatible Huisgen Cycloaddition
VIEW Publication